Xylem's Board appointed Mattew F. Pine, age 52, as the Company's President and Chief Executive Officer to succeed Mr. Decker and to serve as a member of the Board, effective January 1, 2024.
Patrick K. Decker will retire from his position as President and Chief Executive Officer and resign from the Board of Directors ("Board") effective December 31, 2023
the Board appointed Aman Narang, the Company’s current Co-President, Co-Founder and Chief Operating Officer, to succeed Mr. Comparato as Chief Executive Officer of the Company, effective January 1, 2024.
Christopher P. Comparato, Chief Executive Officer and Chairperson of the Board of Toast, Inc. (the “Company”), informed the Company’s Board of Directors (the “Board”) that he will step down as Chief Executive Officer of the Company, effective January 1, 2024.
Departed
Xianchang Ma
Director, Chief Executive Officer and Chief Financial Officer
Tengjun Biotechnology Corp.
Effective
2023-08-03
Successor
Caihong Qu
Filed
September 5, 2023, 7:59 PM ET
who passed away on August 3, 2023
Appointed
(interim)
Caihong Qu
interim Chief Executive Officer and Chief Financial Officer
Tengjun Biotechnology Corp.
Effective
2023-08-10
Filed
September 5, 2023, 7:59 PM ET
On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company
Role change
Doug Rice
Chief Financial Officer and Chief Accounting Officer
After discussions with MiMedx Group, Inc. (the “Company”), including Doug Rice, the Company’s recently appointed Chief Financial Officer, William Phelan, who had previously been serving as Chief Accounting Officer, and the Company agreed that it was in the Company’s best interests to combine the roles of Chief Financial Officer and Chief Accounting Officer into a single position, which Mr. Rice assumed, effective on September 1, 2023.
On September 1, 2023, John McVicar (“Mr. McVicar”) was appointed as Chief Financial Officer of Camber Energy, Inc., a Nevada corporation (the “Company”), replacing Frank W. Barker, Jr. (“Mr. Barker”) as the Company’s Chief Financial Officer.
On August 29, 2023, in connection with the termination of the Master Services Agreement, Sandra A. Gardiner notified the Company of her resignation as the Company’s Acting Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective as of the Termination Date.
Effective November 27, 2023 (the “Effective Date”), Gayle Jardine will step down from her position as Interim Chief Financial Officer of Coda Octopus Group, Inc. (the “Company”), in connection with the appointment of a new Chief Financial Officer as disclosed below.
On September 5, 2023, the Company announced the appointment of Kendra Adams as its Chief Financial Officer, Treasurer and principal financial officer, effective as of Monday September 18, 2023.
On August 30, 2023, Lauren White informed us of her intent to resign from C4 Therapeutics, Inc. (the “ Company ”), effective as of Friday September 15, 2023.
Effective as of September 1, 2023, the Board of Directors (the “ Board ”) of 374Water Inc. (the “ Company ”) appointed Jeff Quick as Interim Chief Executive Officer (“ CEO ”) of the Company.
Departed
John Price
Chief Financial Officer
Assure Holdings Corp.
Effective
2023-11-17
Filed
September 5, 2023, 7:59 PM ET
On August 29, 2023, John Price resigned as Chief Financial Officer of the Company, with such resignation to be effective on November 17, 2023.
Appointed
H. Joseph Prodan
Chief Financial Officer
Bird Global, Inc.
Effective
2023-08-30
Filed
September 5, 2023, 7:59 PM ET
On September 5, 2023, the Board announced its appointment of H. Joseph Prodan to succeed Michael Washinushi as the Company’s Chief Financial Officer, effective on August 30, 2023.
Role change
(interim)
Michael Washinushi
Interim Chief Executive Officer
Bird Global, Inc.
Effective
2023-08-30
Successor
H. Joseph Prodan
Filed
September 5, 2023, 7:59 PM ET
On September 5, 2023, the Board announced its appointment of H. Joseph Prodan to succeed Michael Washinushi as the Company’s Chief Financial Officer, effective on August 30, 2023.
Departed
Scott Sutton
President, Chief Executive Officer and Chairman of the Board
On September 1, 2023, Olin Corporation (the “Company”) announced that, by mutual agreement, Mr. Scott Sutton will step down as the Company’s President, Chief Executive Officer and Chairman of the Board in the first half of 2024.
Jorgen Pedersen ceased to be Chief Operating Officer of the Company and its subsidiaries (the “Company Group”) on July 12, 2023 (the “Separation Date”).
Philip O. Strawbridge stepped down from his position as Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer of Centrus Energy Corp. (the “Company”), effective August 31, 2023.
Appointed
Kevin J. Harrill
Senior Vice President, Chief Financial Officer and Treasurer
the Board of Directors (the “Board”) of the Company appointed Kevin J. Harrill to succeed Philip O. Strawbridge as Senior Vice President, Chief Financial Officer and Treasurer, effective September 1, 2023.
On August 28, 2023, the Company and Mr. D’Amico mutually agreed to terminate Mr. D’Amico’s employment with the Company.
Appointed
Seth Tasker
Chief Executive Officer
INFINITY PHARMACEUTICALS, INC.
Effective
2023-09-01
Filed
September 1, 2023, 7:59 PM ET
On August 29, 2023, the Board approved the appointment, effective as of September 1, 2023, of Seth Tasker, J.D., 45, as Chief Executive Officer of the Company.
Role change
Adelene Perkins
Chief Executive Officer
INFINITY PHARMACEUTICALS, INC.
Effective
2023-09-01
Successor
Seth Tasker
Filed
September 1, 2023, 7:59 PM ET
the Board approved the termination, without cause, of the employment of Adelene Perkins as Chief Executive Officer of the Company, and Robert Ilaria, Jr., M.D., as Chief Medical Officer of the Company, effective September 1, 2023.
Appointed
(interim)
Ginger Graham
interim Chief Executive Officer
Walgreens Boots Alliance, Inc.
Effective
2023-09-01
Filed
September 1, 2023, 7:59 PM ET
The Board has appointed Ginger Graham as the Company’s interim Chief Executive Officer, effective September 1, 2023.
Departed
Rosalind Brewer
Chief Executive Officer and Director
Walgreens Boots Alliance, Inc.
Effective
2023-08-31
Successor
Ginger Graham
Filed
September 1, 2023, 7:59 PM ET
Rosalind Brewer had mutually agreed that Ms. Brewer would step down as the Company’s Chief Executive Officer and as a member of the Board, effective August 31, 2023.
Appointed
Sarah Youngwood
Executive Vice President and Chief Financial Officer
On August 29, 2023, Nasdaq, Inc. (the “Company”) announced the appointment of Ms. Sarah Youngwood as Executive Vice President and Chief Financial Officer, effective as of December 1, 2023
On August 29, 2023, R. Clay Hulette notified Kentucky First Federal Bancorp (the “Company”) that effective January 2, 2024, he is retiring from his position as Vice President and Chief Financial Officer of the Company and his position as Frankfort Area President of its subsidiary First Federal Savings Bank of Kentucky.
Role change
Luvleen Sidhu
Chief Executive Officer
BM Technologies, Inc.
Effective
2023-08-29
Filed
September 1, 2023, 7:59 PM ET
Ms. Luvleen Sidhu, the Company’s Chief Executive Officer, will serve as the Company’s sole CEO effective with Mr. Singh’s resignation.
On August 28, 2023, First Western Financial, Inc. (the "Company") announced the appointment, effective October 1, 2023, of David R. Weber to serve as its Chief Financial Officer and Treasurer.
appointed Kevin Landis, the current Chairman of the Board of Directors, and President and Chief Executive Officer of the Company to serve as the Company’s Chief Financial Officer, also effective on August 30, 2023.
On August 30, 2023, Omar Billawala resigned as the Chief Financial Officer of Firsthand Technology Value Fund, Inc. (the “Company”), effective on that date.
Effective August 29, 2023, Esports Entertainment Group, Inc. (the “Company”) announced the appointment of Michael Villani, 47, as the permanent Chief Financial Officer, from his previous role as Interim Chief Financial Officer and Financial Controller.
Departed
Kenneth Pucheu
Principal Financial Officer
NEXTIER OILFIELD SOLUTIONS INC.
Effective
2023-09-01
Filed
September 1, 2023, 7:59 PM ET
ceased his respective service as an officer of the Company.
Departed
Robert W. Drummond
Principal Executive Officer
NEXTIER OILFIELD SOLUTIONS INC.
Effective
2023-09-01
Filed
September 1, 2023, 7:59 PM ET
ceased his respective service as an officer of the Company.
On August 31, 2023, Aurora Operations, Inc., a wholly owned subsidiary of the Company, and Mr. Tame entered into a Separation Agreement and Release (the “Separation Agreement”).
Appointed
Greg Ethridge
Chief Financial Officer
Canoo Inc.
Effective
2023-08-28
Filed
August 31, 2023, 7:59 PM ET
On August 28, 2023, Canoo Inc. (the “ Company ”) announced the appointment of Greg Ethridge as Chief Financial Officer of the Company, effective immediately.
Departed
Ken Manget
Chief Financial Officer
Canoo Inc.
Effective
2023-08-26
Successor
Greg Ethridge
Filed
August 31, 2023, 7:59 PM ET
Effective August 26, 2023, Ken Manget, who served as the Company’s Chief Financial Officer since January 26, 2023, will no longer serve as the Company’s Chief Financial Officer.
the Company announced that, effective September 15, 2023, Marc E. Binda would serve as Chief Financial Officer and Treasurer.
Appointed
James B. Tananbaum
Director, President and Chief Executive Officer
PARDES BIOSCIENCES, INC.
Effective
2023-08-30
Filed
August 31, 2023, 7:59 PM ET
The directors and officers of Merger Sub immediately prior to the Effective Time were James B. Tananbaum, Director, President and Chief Executive Officer, and Dennis D. Ryan, director, Chief Financial Officer and Secretary.
Appointed
Dennis D. Ryan
Director, Chief Financial Officer and Secretary
PARDES BIOSCIENCES, INC.
Effective
2023-08-30
Filed
August 31, 2023, 7:59 PM ET
The directors and officers of Merger Sub immediately prior to the Effective Time were James B. Tananbaum, Director, President and Chief Executive Officer, and Dennis D. Ryan, director, Chief Financial Officer and Secretary.
On August 31, 2023, Methode Electronics, Inc. (the “Company”) announced that Donald W. Duda, its President and Chief Executive Officer, plans to retire once a successor is found.
On August 29, 2023, Jaisim Shah notified the Board that he was retiring from the Board, all committees of the Board, his position as the Chief Executive Officer and President of the Company and any position as a director or officer of any subsidiary of the Company, effective as of and contingent upon the closing of the Oramed Transaction.
Departed
John Trainer
Chief Financial Officer and Principal Financial and Accounting Officer
NexImmune, Inc.
Effective
2023-09-02
Successor
Timothy Stover
Filed
August 31, 2023, 7:59 PM ET
the Company and John Trainer, the Company’s Chief Financial Officer and the Company’s Principal Financial and Accounting Officer, agreed on August 30, 2023 that Mr. Trainer’s employment with the Company will terminate effective as of September 2, 2023
Appointed
Timothy Stover
Principal Financial and Accounting Officer
NexImmune, Inc.
Effective
2023-09-02
Filed
August 31, 2023, 7:59 PM ET
On August 30 2023, Timothy Stover, the Company’s Vice President, Corporate Controller, was appointed the Principal Financial and Accounting Officer of the Company effective as of September 2, 2023
On August 29, 2023, the Company announced the retirement and resignation of David Kagan and the appointment of Dr. Paul Jacobs as Chief Executive Officer effective immediately.
Appointed
Archit Shah
Chief Financial Officer
iCoreConnect Inc.
Effective
2023-09-01
Filed
August 31, 2023, 7:59 PM ET
We entered into an employment agreement, effective September 1, 2023, with Archit Shah, pursuant to which he agreed to serve as our Chief Financial Officer
Appointed
Robert McDermott
Chief Executive Officer
iCoreConnect Inc.
Effective
2023-09-01
Filed
August 31, 2023, 7:59 PM ET
We entered into an employment agreement, effective September 1, 2023, with Robert McDermott, pursuant to which he agreed to serve as our Chief Executive Officer
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.